We are pleased to let you know that our EMPIRICAL abstract (see below) has been accepted for the Poster Walk.
Poster Walk
| Title | 30 – Suboptimal Lopinavir Exposure in Infants 1-12 Months on Rifampicin Treatment Receiving Double-Dosed or Semi-superboosted Lopinavir/Ritonavir; Results from the EMPIRICAL Trial. |
| Paper Number | 30 |
| Paper Status | Poster Walk |
| Session Details | Poster Walks Wednesday, Jul 27, 2022 6:15 PM – 7:30 PM |
| Presenting Author | Mr. Tom Jacobs Affiliations: Clinical Pharmacy Department, Radboudumc, Nijmegen, The Netherlands |
For More details please see the web